Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities

Chimeric antigen receptor (CAR) therapies such as tisagenlecleucel, indicated for children and young adults with relapsed and/or refractory CD19+ acute lymphoblastic leukemia (ALL), have been associated with striking treatment outcomes and overall survival. Yet, they are also associated with unique...

Full description

Bibliographic Details
Main Authors: Avis Harden, Dristhi Ragoonanan, Daryl Anildes-Gubman, David McCall, Kathleen Faltus, Sarah Featherston, Basirat Shoberu, Jerelyn R. Moffet, Demetrios Petropoulos, Sajad J. Khazal, Shehla Razvi, Kris M. Mahadeo, Priti Tewari
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01227/full
_version_ 1819168556619661312
author Avis Harden
Dristhi Ragoonanan
Daryl Anildes-Gubman
David McCall
Kathleen Faltus
Sarah Featherston
Basirat Shoberu
Jerelyn R. Moffet
Demetrios Petropoulos
Sajad J. Khazal
Shehla Razvi
Kris M. Mahadeo
Priti Tewari
author_facet Avis Harden
Dristhi Ragoonanan
Daryl Anildes-Gubman
David McCall
Kathleen Faltus
Sarah Featherston
Basirat Shoberu
Jerelyn R. Moffet
Demetrios Petropoulos
Sajad J. Khazal
Shehla Razvi
Kris M. Mahadeo
Priti Tewari
author_sort Avis Harden
collection DOAJ
description Chimeric antigen receptor (CAR) therapies such as tisagenlecleucel, indicated for children and young adults with relapsed and/or refractory CD19+ acute lymphoblastic leukemia (ALL), have been associated with striking treatment outcomes and overall survival. Yet, they are also associated with unique and potentially life-threatening complications. Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS) are generally reversible complications of CAR therapies, but many patients may require critical care support especially if they are not promptly recognized and appropriately managed by frontline healthcare staff. As CAR therapies become more widely available, it is important that inter-professional staff members be aware of general principles regarding diagnosis and management. We hypothesized that an inter-professional education (IPE) simulation-based education intervention (CAR-TEAM) would improve knowledge base and confidence regarding complications of CAR therapies among inter-professional staff. Here, we demonstrate that following CAR-TEAM training, >90% of participants demonstrated knowledge proficiency and confidence in the IPE content area. CAR-TEAM training may serve as an important tool to establish initial and continued competency among sites introducing CAR therapies.
first_indexed 2024-12-22T19:05:29Z
format Article
id doaj.art-6b030ac93a1b4942927d8216844f199d
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-22T19:05:29Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-6b030ac93a1b4942927d8216844f199d2022-12-21T18:15:49ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-08-011010.3389/fonc.2020.01227555516Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR ToxicitiesAvis Harden0Dristhi Ragoonanan1Daryl Anildes-Gubman2David McCall3Kathleen Faltus4Sarah Featherston5Basirat Shoberu6Jerelyn R. Moffet7Demetrios Petropoulos8Sajad J. Khazal9Shehla Razvi10Kris M. Mahadeo11Priti Tewari12Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesTeaching, Interprofessional and Simulation Education Center, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Blood and Marrow Transplant, Department of Pediatrics, Duke Children's Hospital, Duke University, Durham, NC, United StatesDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Pediatrics, CARTOX Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesChimeric antigen receptor (CAR) therapies such as tisagenlecleucel, indicated for children and young adults with relapsed and/or refractory CD19+ acute lymphoblastic leukemia (ALL), have been associated with striking treatment outcomes and overall survival. Yet, they are also associated with unique and potentially life-threatening complications. Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS) are generally reversible complications of CAR therapies, but many patients may require critical care support especially if they are not promptly recognized and appropriately managed by frontline healthcare staff. As CAR therapies become more widely available, it is important that inter-professional staff members be aware of general principles regarding diagnosis and management. We hypothesized that an inter-professional education (IPE) simulation-based education intervention (CAR-TEAM) would improve knowledge base and confidence regarding complications of CAR therapies among inter-professional staff. Here, we demonstrate that following CAR-TEAM training, >90% of participants demonstrated knowledge proficiency and confidence in the IPE content area. CAR-TEAM training may serve as an important tool to establish initial and continued competency among sites introducing CAR therapies.https://www.frontiersin.org/article/10.3389/fonc.2020.01227/fullinter-professionaleducationsimulation-basedcytokine release syndrome (CRS)immune effector cell-associated neurotoxicity (ICANS)
spellingShingle Avis Harden
Dristhi Ragoonanan
Daryl Anildes-Gubman
David McCall
Kathleen Faltus
Sarah Featherston
Basirat Shoberu
Jerelyn R. Moffet
Demetrios Petropoulos
Sajad J. Khazal
Shehla Razvi
Kris M. Mahadeo
Priti Tewari
Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
Frontiers in Oncology
inter-professional
education
simulation-based
cytokine release syndrome (CRS)
immune effector cell-associated neurotoxicity (ICANS)
title Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
title_full Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
title_fullStr Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
title_full_unstemmed Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
title_short Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
title_sort chimeric antigen receptor teamwork education assessment and management car team a simulation based inter professional education ipe intervention for management of car toxicities
topic inter-professional
education
simulation-based
cytokine release syndrome (CRS)
immune effector cell-associated neurotoxicity (ICANS)
url https://www.frontiersin.org/article/10.3389/fonc.2020.01227/full
work_keys_str_mv AT avisharden chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT dristhiragoonanan chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT darylanildesgubman chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT davidmccall chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT kathleenfaltus chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT sarahfeatherston chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT basiratshoberu chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT jerelynrmoffet chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT demetriospetropoulos chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT sajadjkhazal chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT shehlarazvi chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT krismmahadeo chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities
AT prititewari chimericantigenreceptorteamworkeducationassessmentandmanagementcarteamasimulationbasedinterprofessionaleducationipeinterventionformanagementofcartoxicities